Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other Non-Current Assets: 2024

Historic Other Non-Current Assets for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $7.8 million.

  • Kura Oncology's Other Non-Current Assets rose 67.40% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 67.40%. This contributed to the annual value of $7.8 million for FY2024, which is N/A change from last year.
  • Kura Oncology's Other Non-Current Assets amounted to $7.8 million in FY2024.
  • In the past 5 years, Kura Oncology's Other Non-Current Assets ranged from a high of $7.8 million in FY2024 and a low of $7.8 million during FY2024.
  • Moreover, its 1-year median value for Other Non-Current Assets was $7.8 million (2024), whereas its average is $7.8 million.